Equities

Matinas BioPharma Holdings Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Matinas BioPharma Holdings Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.63
  • Today's Change0.020 / 3.23%
  • Shares traded23.94k
  • 1 Year change+5.00%
  • Beta1.3143
Data delayed at least 15 minutes, as of Feb 13 2026 19:01 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

As of last trade, Matinas BioPharma Holdings Inc (MTNB:ASQ) traded at 0.63, 32.69% above the 52 week low of 0.4748 set on Apr 08, 2025.
52-week range
Today
0.4748Apr 08 20253.09Aug 15 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.6101
High0.6326
Low0.5806
Bid0.600
Offer0.6327
Previous close0.6103
Average volume35.22k
Shares outstanding6.41m
Free float4.99m
P/E (TTM)--
Market cap3.91m USD
EPS (TTM)-3.30
USD
Data delayed at least 15 minutes, as of Feb 13 2026 19:01 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.